menu search

Blackstone's gray on mideast conflict, upenn, inflation

Blackstone President and COO Jon Gray discusses the market implications of the Israel-Hamas war, his commitment to funding low-income students and ...

October 19, 2023, 10:59 am

Pfizer wins unconditional eu antitrust okay for $43 bln seagen buy

U.S. pharmaceutical company Pfizer gained unconditional EU antitrust approval on Thursday for its proposed $43 billion acquisition of ...

October 19, 2023, 10:54 am

Bristol myers's injectable kindey cancer drug found non-inferior to iv form

Bristol Myers Squibb said on Thursday its injectable form of blockbuster cancer drug Opdivo was found t...

October 19, 2023, 7:11 am

Cytomx therapeutics presents preclinical profile of epcam-directed antibody drug conjugate cx-2051 at 2023 world adc conference

– CX-2051 is tailored for treatment of EpCAM-expressing cancers by matching target expression and tum...

October 18, 2023, 8:30 pm

Lisata's (lsta) lead cancer drug gets ec's orphan tag, stock up

Lisata (LSTA) shares rise 6.6% after its lead candidate, LSTA1, receives orphan drug designation from the European Commission for treating pancreatic ...

October 18, 2023, 12:47 pm

3 gene editing stocks to generate super-charged gains

Gene editing is revolutionizing how the world approaches medicine. In fact, by “simply” removing cells from the body, editing them, and reintroduc...

October 18, 2023, 11:05 am

Iq-ai higlights use of subsidiary's software in brain cancer study

IQ-AI has highlighted a new study into a rare form of brain cancer that used subsidiary Imaging  Biome...

October 18, 2023, 11:01 am

Eli lilly is buying another european cancer firm mablink bioscience

Eli Lilly & Co (NYSE: LLY) is buying Mablink Bioscience – a French biotechnology company that focuses primarily on the next-generation, antibody-dru...

October 18, 2023, 10:01 am

Precipio to report $4.5m q3-2023 revenues, double from q3-2022

NEW HAVEN, Conn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc....

October 18, 2023, 9:00 am

Astrazeneca shares fall as abstract for lung cancer trial data disappoints

Shares in AstraZeneca fell more than 4% on Wednesday after the publication of an abstract on its experimental precision drug's use in lung ...

October 18, 2023, 8:26 am

Successful exit of portfolio company and major invest in ai and digital health in early cancer detection, valued at chf 23.3 million

Xlife Sciences AG / Key word (s): Disposal/Investment Successful exit of portfolio company and major invest in AI and digital health in early ...

October 18, 2023, 5:44 am

Scancell to speak at prestigious vaccine event

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing immunotherapies for cancer and infect...

October 18, 2023, 3:14 am

J&j's medical device sales feel the side effects of weight-loss drugs

Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%.  The pha...

October 17, 2023, 11:05 pm

Oric pharmaceuticals to present initial phase 1b clinical data for oric 114 in egfr/her2 exon 20 mutated nsclc at the european society of medical oncology (esmo) congress 2023

Company to host a conference call and webcast on Saturday, October 21, 2023, at 9:00 am ET featuring Dr. Alexander Spira to discuss initial data and p...

October 17, 2023, 4:30 pm

Akoya biosciences announces peer-reviewed publication using ultrahigh-plex spatial phenotyping of head and neck cancer to identify distinct immune and metabolic signatures

MARLBOROUGH, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today anno...

October 17, 2023, 2:22 pm

Merck's (mrk) keytruda gets fda nod in sixth nsclc indication

FDA has approved the expanded use of Merck's (MRK) Keytruda in certain patients with early-stage non-small cell lung ...

October 17, 2023, 12:46 pm

Preclinical data demonstrate anti-siglec-15 treatment reduced bone loss and enhanced bone quality in mice with moderate-to-severe osteogenesis imperfecta (oi)

Data Presented at the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting BELTSVILLE, Md., Oct. 17, 2023 (GLOBE NEWSWIRE) — N...

October 17, 2023, 12:05 pm

Sellas life sciences to present final data from phase 1/2 study of galinpepimut-s in combination with keytruda® (pembrolizumab) in patients with wt1+ platinum-resistant advanced ovarian cancer at the

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS'' or the “Company”), a late-stage clinical b...

October 17, 2023, 8:45 am

Apollomics announces presentations of vebreltinib data at esmo 2023

FOSTER CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (the “Company”), a late-stage clinical biopharmaceutical co...

October 16, 2023, 10:55 pm

Elucent announces new partnership with survivingbreastcancer.org

The Medical Device Company Will Sponsor the Educational Organization to Expand Its Reach to Patients, Families, Caregivers EDEN PRAIRIE, Minn., Oct. 1...

October 16, 2023, 9:02 pm


Search within

Pages Search Results: